Director, Health Economics & Outcomes Research- Hematology Oncology
Regeneron Pharmaceuticals(5 months ago)
About this role
A strategic, scientifically focused leader role on Regeneron’s Global HEOR team supporting the hematologic oncology portfolio. This newly created position will shape HEOR strategies to influence clinical development, regulatory decisions, and global market access for novel therapies. The role is based in Sleepy Hollow, NY and requires onsite presence four days per week.
Required Skills
- HEOR Strategy
- Health Economics
- Economic Modeling
- RWE
- Epidemiology
- COA Development
- HTA Submissions
- Regulatory Engagement
- Vendor Management
- Collaboration
+1 more
Qualifications
- PhD
- MS
- MD
- PharmD
- B. Pharm
- RN with Master’s
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
View more jobs at Regeneron Pharmaceuticals →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at Regeneron Pharmaceuticals
QA Validation Specialist
Regeneron Pharmaceuticals(7 days ago)
Temp QC Analyst (HPLC/Micro/Tech Resource)
Regeneron Pharmaceuticals(7 days ago)
Process Development Engineer III Analytics Automation
Regeneron Pharmaceuticals(7 days ago)
Director, Culture & Inclusive Science
Regeneron Pharmaceuticals(7 days ago)
Similar Jobs
Health Economics & Outcomes Research (HEOR) Senior Manager, Oncology
Amgen(2 months ago)
Vice President, Health Economics and Outcomes Research
Crinetics Pharmaceuticals(1 month ago)
Global Health Economics & Outcomes Research (HEOR) Senior Manager
Amgen(1 month ago)
Global Health Economics & Outcomes Research (HEOR) Senior Manager
Amgen(1 month ago)
Director, Global Health Economics & Outcomes Research (HEOR)
Dyne Therapeutics(1 month ago)
Oncology Outcomes Research Intern - Summer 2026
American Association of Physicists in Medicine(1 month ago)